Life Insurance Corporation of India announced it has acquired additional stake in Dr. Reddy’s Laboratories Limited. Post acquisition, the company holds a 5.646 per cent stake in the pharmaceutical major. According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that…
The Sistema Group company, Binnopharm Group, one of the leading pharmaceutical production companies in Russia via its affiliate Joint Stock Company ‘Alium’, and Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”), an integrated global pharmaceutical company, announced the signing of a deal that will allow Binnopharm Group to acquire…
Dr. Reddy’s Laboratories Limited announced the appointment of Dr. K P Krishnan to its Board of Directors, effective January 7, 2022. According to the company’s exchange filing, “we would like to inform you that Dr. K P Krishnan (DIN: 01099097) has been appointed as an Additional Director, categorized as Independent, on the Board of Dr.…
Dr. Reddy’s Laboratories Ltd., and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India. This will be a multicenter and randomized controlled study, which will include safety and immunogenicity study, Dr.…
Dr. Swatee Sarangi has been appointed as the Global Head – Learning, Leadership and Organizational Development of Dr. Reddy’s Laboratories. Sarangi moves from Larsen & Toubro where she was a Head – Learning & Organizational Development.